Whitehawk Therapeutics (WHWK) Operating Expenses (2010 - 2026)
Whitehawk Therapeutics (WHWK) posted quarterly Operating Expenses of $23.5 million for Q1 2026, up 5.18% year-over-year from $22.4 million in Q1 2025, and down 5.48% quarter-over-quarter from $24.9 million in Q4 2025.
Whitehawk Therapeutics (WHWK) Operating Expenses (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has reported Operating Expenses for 17 consecutive years, with $23.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 5.18% year-over-year to $23.5 million; the TTM figure through Mar 2026 stood at $122.7 million (up 34.93% YoY), while the FY2025 annual figure was $121.5 million, up 30.08% from the prior year.
- Operating Expenses fell to $23.5 million in Q1 2026 per WHWK's latest filing, from $24.9 million in the prior quarter.
- Across five years, Operating Expenses topped out at $54.7 million in Q2 2025 and bottomed at $16.1 million in Q1 2022.
- Historically, Operating Expenses has averaged $24.3 million across 5 years, with a median of $22.7 million in 2023.
- On a YoY basis, Operating Expenses climbed as much as 462.5% in 2022 and fell as far as 77.92% in 2022.
- Whitehawk Therapeutics' Operating Expenses stood at $20.7 million in 2022, then gained by 16.14% to $24.0 million in 2023, then climbed by 8.94% to $26.2 million in 2024, then fell by 4.97% to $24.9 million in 2025, then fell by 5.48% to $23.5 million in 2026.
- Business Quant data shows WHWK's Operating Expenses at $23.5 million in Q1 2026, $24.9 million in Q4 2025, and $19.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Whitehawk Therapeutics | 369.67 Mn | 74.92 Mn | - | 18.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.11 Mn |
| Mar 31, 2026 | 23.52 Mn |
| Dec 31, 2025 | 24.89 Mn |
| Sep 30, 2025 | 19.55 Mn |
| Jun 30, 2025 | 54.75 Mn |
| Mar 31, 2025 | 22.36 Mn |
| Dec 31, 2024 | 26.19 Mn |
| Sep 30, 2024 | 20.63 Mn |
| Jun 30, 2024 | 21.76 Mn |
| Mar 31, 2024 | 24.87 Mn |
| Dec 31, 2023 | 24.04 Mn |
| Sep 30, 2023 | 23.81 Mn |
| Jun 30, 2023 | 25.75 Mn |
| Mar 31, 2023 | 22.69 Mn |
| Dec 31, 2022 | 20.70 Mn |
| Sep 30, 2022 | 19.28 Mn |
| Jun 30, 2022 | 21.80 Mn |
| Mar 31, 2022 | 16.12 Mn |
| Dec 31, 2021 | 16.95 Mn |
| Sep 30, 2021 | 87.31 Mn |